Neurologic injury is a potentially devastating consequence of heart surgery. Between 1% and 5% of patients undergoing cardiopulmonary bypass have postoperative strokes and 30% to 80% of patients demonstrate some neurologic dysfunction postoperatively. This review focuses on anatomic, molecular and clinical markers of neurologic injury following cardiopulmonary bypass. Attention is directed to the molecular mechanisms underlying neurologic injury and clinical biochemical markers of injury during heart surgery. Novel strategies to modulate injury are also discussed.
Get full access to this article
View all access options for this article.
References
1.
1. Salazar JD, Wityk RJ, Grega MA, et al: Stroke after cardiac surgery: Shortand long-term outcomes. Ann Thorac Surg72(4):1195-1201; discussion 1201-1202, 2001.
2.
2. Tuman KJ, McCarthy RJ, Najafi H, Ivankovich AD: Differential effects of advanced age on neurologic and cardiac risks of coronary artery operations. J Thorac Cardiovasc Surg104(6):1510-1517, 1992.
3.
3. Roach GW, Kanchuger M, Mangano CM, et al: Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med335(25):1857-1863, 1996.
4.
4. Shaw PJ, Bates D, Cartlidge NE, et al: Early neurological complications of coronary artery bypass surgery. Br Med J (Clin Res Ed). 291(6506):1384-1387, 1985.
5.
5. Savageau JA, Stanton BA, Jenkins CD, Klein MD: Neuropsychological dysfunction following elective cardiac operation. I. Early assessment. J Thorac Cardiovasc Surg84(4):585-594, 1982.
6.
6. Newman MF, Kirchner JL, Phillips-Bute B, et al: Longitudinal assessment of neurocognitive junction after coronary-artery bypass surgery. N Engl J Med344(6):395-402, 2001.
7.
7. Stump DA, Jones TJ, Rorie KD: Neurophysiologic monitoring and outcomes in cardiovascular surgery. J Cardiothorac Vasc Anesth13(5):600-613, 1999.
8.
8. Arrowsmith JE, Grocott HP, Newman MF: Neurologic risk assessment, monitoring and outcome in cardiac surgery. J Cardiothorac Vasc Anesth13(6):736-743, 1999.
9.
9. Smith PL, Taylor KM: Cardiac surgery and the brain. London: Edward Arnold, 1993.
10.
10. Murkin JM: Anesthesia, the brain, and cardiopulmonary bypass. Ann Thorac Surg56(6):1461-1463, 1993.
11.
11. Juurlink BH: Response of glial cells to ischemia: Roles of reactive oxygen species and glutathione. Neurosci Biobehav Rev21(2):151-166, 1997.
12.
12. Nagahiro S, Uno M, Sato K, et al: Pathophysiology and treatment of cerebral ischemia. J Med Invest45(1-4):57-70, 1998.
13.
13. Pantoni L, Sarti C, Inzitari D: Cytokines and cell adhesion molecules in cerebral ischemia: Experimental bases and therapeutic perspectives. Arterioscler Thromb Vasc Biol18(4):503-513, 1998.
14.
14. Heiss WD, Rosner G: Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol14(3):294-301, 1983.
15.
15. Carney JM, Floyd RA: Protection against oxidative damage to CNS by alpha-phenyl-tertbutyl nitrone (PBN) and other spin-trapping agents: A novel series of nonlipid free radical scavengers. J Mol Neurosci3(1):47-57, 1991.
16.
16. Beetsch JW, Park TS, Dugan LL, et al: Xanthine oxidasederived superoxide causes reoxygenation injury of ischemic cerebral endothelial cells. Brain Res786(1-2):89-95, 1998.
17.
17. Chan PH: Role of oxidants in ischemic brain damage. Stroke27(6):1124-1129, 1996.
18.
18. Floyd RA, Carne JM: Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol32(Suppl): S22-S27, 1992.
19.
19. Kontos HA: George E Brown memorial lecture. Oxygen radicals in cerebral vascular injury. Circ Res57(4):508-516, 1985.
20.
20. Ginsberg MD, Watson BD, Busto R, et al: Peroxidative damage to cell membranes following cerebral ischemia. A cause of ischemic brain injury?Neurochem Pathol9:171-193, 1988.
21.
21. Dirnagl U, Lindauer U, Them A, et al: Global cerebral ischemia in the rat: Online monitoring of oxygen free radical production using chemiluminescence in vivo. J Cereb Blood Flow Metab15(6):929-940, 1995.
22.
22. Piantadosi CA, Zhang J: Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke27(2):327-331; discussion 332, 1996.
23.
23. DeGraba TJ: The role of inflammation after acute stroke: Utility of pursuing antiadhesion molecule therapy. Neurology51(3 Suppi 3):S62-S68, 1998.
24.
24. Fabian RH, Kent TA: Superoxide anion production during reperfusion is reduced by an antineutrophil antibody after prolonged cerebral ischemia. Free Radic Biol Med26(3-4): 355-361, 1999.
25.
25. Anonym: Use of anti-ICAM-1 therapy in ischemic stroke: Results of the Entimomab Acute Stroke Trial. Neurology57(8):1428-1434, 2001.
26.
26. Gehrmann J, Banati RB, Wiessner C, et al: Reactive microglia in cerebral ischaemia: An early mediator of tissue damage?Neuropathol Appl Neurobiol21(4):277-289, 1995.
27.
27. Chen J, Weinstein PR, Graham SH: Attenuation of post-ischemic brain hypoperfusion and reperfusion injury by the cyclooxygenase-lipoxygenase inhibitor BW755CJ Neurosurg83(1):99-104, 1995.
28.
28. Takuma K, Lee E, Kidaware M, et al: Apoptosis in Ca2 + reperfusion injury of cultured astrocytes: Roles of reactive oxygen species and NF-kappa B activation. Eur J Neurosci11(12):4204-4212, 1999.
29.
29. Kuroda S, Siesjo BK: Reperfusion damage following focal ischemia: Pathophysiology and therapeutic windows. Clin Neurosci4(4):199-212, 1997.
30.
30. Pahlmark K, Folbergrova J, Smith ML, et al: Effects of dimethylthiourea on selective neuronal vulnerability in forebrain ischemia in rats. Stroke24(5):731-736; discussion 736-737, 1993.
31.
31. Fujimura M, Morita-Fujimura Y, Narasimhan P, et al: Copper-zinc superoxide dismutase prevents the early decrease of apuriniclapyrim idinic endonuclease and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke30(11):2408-2415, 1999.
32.
32. Cao X, Phillis JW: Alpha-phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res644(2):267-272, 1994.
33.
33. Schulz JB, Matthews RT, Jenkins BG, et al: Improved therapeutic window for treatment of histotoxic hypoxia with a free radical spin trap. J Cereb Blood Flow Metab15(6):948-952, 1995.
34.
34. Langley SM, Chai PJ, Jaggers JJ, et al: The free radical spin trap alpha-phenyl-tertbutyl nitrone attenuates the cerebral response to deep hypothermic ischemia. J Thorac Cardiovasc Surg119(2):305-313, 2000.
35.
35. Huang SS, Tsai SK, Chih CL, et al: Neuroprotective effect of hexasulfobutylated C60 on rats subjected to focal cerebral ischemia. Free Radic Biol Med30(6):643-649, 2001.
36.
36. Yang GY, Pang L, Ge HL, et al: Attenuation of ischemia-induced mouse brain injury by SAG, a redox-inducible antioxidant protein. J Cereb Blood Flow Metab21(6):722-733, 2001.
38. Garthwaite J, Charles SL, Chess-Williams R: Endotheliumderived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature336(6197):385-388, 1988.
39.
39. Huang Z, Huang PL, Ma J, et al: Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab16(5):981-987, 1996.
40.
40. Murphy S, Simmons ML, Agullo L, et al: Synthesis of nitric oxide in CNS glial cells. Trends Neurosci16(8):323-328, 1993.
41.
41. Kuppusamy P, Ohnishi ST, Numagami Y, et al: Three-dimensional imaging of nitric oxide production in the rat brain subjected to ischemia-hypoxia. J Cereb Blood Flow Metab15(6):899-903, 1995.
42.
42. Olesen SP, Moller A, Mordvintcev PI, et al: Regional measurements of NO formed in vivo during brain ischemia. Acta Neurol Scand95(4):219-224, 1997.
43.
43. Dawson VL, Dawson TM, Bartley DA, et al: Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci13(6):2651-2661, 1993.
45. Bolanos JP, Almeida A, Stewart V, et al: Nitric oxide-mediated mitochondrial damage in the brain: Mechanisms and implications for neurodegenerative diseases. J Neurochem68(6):2227-2240, 1997.
46.
46. Beckman JS, Beckman TW, Chen J, et al: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA87(4):1620-1624, 1990.
47.
47. Sato S, Tominaga T, Ohnishi T, et al: EPR spin-trapping study of nitric oxide formation during bilateral carotid occlusion in the rat. Biochim Biophys Acta1181(2):195-197, 1993.
48.
48. Tominaga T, Sato S, Ohnishi T, et al: Potentiation of nitric oxide formation following bilateral carotid occlusion andfocal cerebral ischemia in the rat: In vivo detection of the nitric oxide radical by electron paramagnetic resonance spin trapping. Brain Res614(1-2):342-346, 1993.
49.
49. Sato S, Tominaga T, Ohnishi T, et al: Electron paramagnetic resonance study on nitric oxide production during brain focal ischemia and reperfusion in the rat. Brain Res647(1):91-96, 1994.
50.
50. Bolanos JP, Almeida A: Roles of nitric oxide in brain hypoxia-ischemia. Biochim Biophys Acta1411 (2-3):415-436, 1999.
51.
51. Dawson DA: Nitric oxide and focal cerebral ischemia: Multiplicity of actions and diverse outcome. Cerebrovasc Brain Metab Rev6(4):299-324, 1994.
52.
52. Iadecola C: Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci20(3):132-139, 1997.
53.
53. Samdani AF, Dawson TM, Dawson VL: Nitric oxide synthase in models of focal ischemia. Stroke28(6):1283-1288, 1997.
54.
54. Huang Z, Huang PL, Panahian N, et al: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science265(5180):1883-1885, 1994.
55.
55. ladecola C, Zhang F, Casey R, et al: Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci17(23):9157-9164, 1997.
56.
56. Persson L, Hardemark HG, Gustafsson J, et al: S100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system. Stroke18(5):911-918, 1987.
57.
57. Moore B, McGregor D: Chromatographic and electrophoretic fractionation of soluble proteins of brain and liver. J Biol Chem240:1647-1653, 1965.
58.
58. Usui A, Kato K, Abe T, et al: S100f protein in blood and urine during open-heart surgery. Clin Chem35(9):1942-1944, 1989.
59.
59. Schafer BW, Heizmann CW: The S100 family of EF-hand calcium-binding proteins: Functions and pathology. Trends Biochem Sci21(4):134-140, 1996.
60.
60. Reeves RH, Yao J, Crowley MR, et al: Astrocytosis and axonal proliferation in the hippocampus of S100P transgenic mice. Proc Natl Acad Sci USA91(12):5359-5363, 1994.
61.
61. Parma AM, Marangos PJ, Goodwin FK: A more sensitive radioimmunoassay for neuron-specific enolase suitable for cerebrospinal fluid determinations. J Neurochem36(3):1093-1096, 1981.
62.
62. Marangos PJ, Schmechel DE: Neuron-specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci10:269-295, 1987.
63.
63. Johnsson P, Lundqvist C, Lindgren A, et al: Cerebral complications after cardiac surgery assessed by S100 and NSE levels in blood. J Cardiothorac Vasc Anesth9(6) :694-699, 1995.
64.
64. Rasmussen LS, Christiansen M, Rasmussen H, et al: Do blood levels of neuron-specific enolase and S100 protein reflect cognitive dysfunction after coronary artery bypass?Acta Anaesthesiol Scand43(5):495-500, 1999.
65.
65. Westaby S, Saatvedt K, White S, et al: Is there a relationship between serum S100J protein and neuropsychologic dysfunction after cardiopulmonary bypass?J Thorac Cardiovasc Surg119(1):132-137, 2000.
66.
66. Georgiadis D, Berger A, Kowatschev E, et al: Predictive value of SlOO, and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery. J Thorac Cardiovasc Surg119(1):138-147, 2000.
67.
67. Jonsson H, Johnsson P, Alling C, et al: S100f after coronary artery surgery: Release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg68(6):2202-2208, 1999.
68.
68. Anderson RE, Hansson LO, Liska J, et al: The effect of cardiotomy suction on the brain injury marker S100j after cardiopulmonary bypass. Ann Thorac Surg69(3):847-850, 2000.
69.
69. Lloyd CT, Ascione R, Underwood MJ, et al: Serum S100 protein release and neuropsychologic outcome during coronary revascularization on the beating heart: A prospective randomized study. J Thorac Cardiovasc Surg119(1):148-154, 2000.
